Clinical trial
A Prospective, Non-randomized, Multicenter, Open-label, Non-comparative, First-in-Man Study to Evaluate the Feasibility and Safety of LAmbre Left Atrial Appendage Occluder
NCT01920412 is registered in ClinicalTrials.gov with Lifetech Scientific (Shenzhen) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Non-randomized, Multicenter, Open-label, Non-comparative, First-in-Man Study to Evaluate the Feasibility and Safety of LAmbre Left Atrial Appendage Occluder
- Lead sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- September 30, 2014
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.